Form 4: Orchestra BioMed CFO Reports Routine Stock Vesting and Tax Withholding

Orchestra BioMed Holdings, Inc.'s Chief Financial Officer, Andrew Lawrence Taylor, reported a routine transaction involving the withholding of shares to cover tax obligations related to the vesting of restricted stock units.

Summary

• Andrew Lawrence Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc. (OBIO), filed a Form 4 statement regarding changes in his beneficial ownership.
• The transaction, dated June 11, 2025, involved the disposition of 28,172 shares of Common Stock.
• This disposition was a withholding by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• The shares were withheld at a price of $3.14 per share.
• No shares were sold in the open market as a result of this vesting and tax satisfaction.
• Following this transaction, Mr. Taylor beneficially owns 400,788 shares of Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While shares were 'disposed of,' it was a non-sale transaction for tax purposes, which is a routine administrative event and does not indicate a lack of confidence from the insider. The CFO still holds a substantial number of shares.

Positives

• The transaction represents a routine tax withholding event, not an open market sale by the CFO, indicating continued holding of equity.
• The CFO retains a significant beneficial ownership of 400,788 shares after the transaction, aligning his interests with shareholders.

Negatives

• The 'disposition' of shares, even for tax purposes, reduces the total number of shares directly held by the insider.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The reporting person clarified that the transaction 'Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.'

Industry Context

This filing represents a routine insider transaction common across publicly traded companies where executives receive equity compensation that vests over time, leading to tax obligations satisfied by share withholding.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-market transaction for tax purposes, not a sale by the CFO. It confirms the CFO's continued equity stake.
• Employees: This transaction is typical for employees receiving equity compensation, reinforcing standard compensation practices.

Key Dates

Keywords

Orchestra BioMed Holdings Inc., OBIO, Andrew Lawrence Taylor, Chief Financial Officer, SEC Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Tax Withholding, Equity Compensation